DEUTSCHE BANK AG\ - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$4,532,000
+22.2%
440,000
+95.6%
0.00%
+50.0%
Q2 2023$3,708,000
+997.0%
225,000
+233.4%
0.00%
Q3 2022$338,000
+10.8%
67,482
-46.0%
0.00%
Q2 2022$305,000
-87.0%
125,000
-63.6%
0.00%
-100.0%
Q1 2022$2,345,000
-15.5%
343,4070.0%0.00%0.0%
Q4 2021$2,775,000
-17.5%
343,4070.0%0.00%
-50.0%
Q3 2021$3,365,000
+3.9%
343,407
-28.6%
0.00%0.0%
Q2 2021$3,238,000
-16.2%
481,194
+12.5%
0.00%0.0%
Q1 2021$3,866,000
+35.3%
427,6760.0%0.00%0.0%
Q4 2020$2,857,000
+27.4%
427,676
-3.9%
0.00%0.0%
Q3 2020$2,243,000
-35.1%
445,057
+4.1%
0.00%
-33.3%
Q2 2020$3,456,000
-26.0%
427,676
-27.3%
0.00%
-25.0%
Q1 2020$4,671,000
+5.2%
588,3070.0%0.00%
+33.3%
Q4 2019$4,441,000
+81.5%
588,3070.0%0.00%
+50.0%
Q3 2019$2,447,000
+43.6%
588,307
-0.2%
0.00%
+100.0%
Q2 2019$1,704,000
+97.2%
589,676
-1.8%
0.00%0.0%
Q1 2019$864,000
+1316.4%
600,700
+2412.9%
0.00%
Q4 2018$61,000
-98.3%
23,905
-97.1%
0.00%
-100.0%
Q3 2018$3,570,000
-67.4%
813,261
-54.5%
0.00%
-66.7%
Q2 2018$10,952,000
+21.0%
1,786,893
+43.9%
0.00%
-25.0%
Q1 2018$9,049,000
+0.0%
1,241,432
+12.5%
0.00%
-33.3%
Q4 2017$9,045,000
-22.5%
1,103,182
-0.8%
0.01%
-25.0%
Q3 2017$11,678,000
-31.3%
1,112,342
-27.8%
0.01%
-33.3%
Q2 2017$16,991,000
+48.5%
1,540,546
+30.3%
0.01%
+50.0%
Q1 2017$11,443,0001,182,2100.01%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,625,000$12,269,0003.04%
GENDELL JEFFREY L 1,146,764$8,658,0001.11%
Broadfin Capital, LLC 1,029,012$7,769,0001.04%
RTW INVESTMENTS, LP 3,401,434$25,681,0000.97%
BRANDES INVESTMENT PARTNERS, LP 3,651,948$27,571,0000.66%
Aristides Capital LLC 71,520$540,0000.42%
Tekla Capital Management LLC 814,588$6,150,0000.23%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 36,100$273,0000.17%
Leap Investments LP 43,481$328,0000.15%
Brown Capital Management 1,829,886$13,816,0000.13%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders